Charan Leng

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

S. Sathyanarayanan, O. Burenkova, S. Jang, 2022, Science advances.

A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties

R. Moniz, S. Estes, S. Sathyanarayanan, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

In vitro characterization of an acetylcholine receptor–transferrin fusion protein for the treatment of myasthenia gravis

M. Heartlein, C. Parng, Dianna M Lundberg, 2010, Autoimmunity.

702 DUAL BLOCKADE OF THE PD-1 CHECKPOINT PATHWAY AND THE ADENOSINERGIC NEGATIVE FEEDBACK SIGNALING PATHWAY WITH A PD-1/CD73 BISPECIFIC ANTIBODY FOR CANCER IMMUNE THERAPY

S. Sathyanarayanan, N. Ross, Kevin Dooley, 2020 .